Cite
APA Citation
Pedraza, F., Ladino, M., & Roth, D. (2016). impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease. Clinical liver disease, 7(5), 112–115. http://access.bl.uk/ark:/81055/vdc_100032499815.0x000003